Sentence examples for this trial will explore from inspiring English sources

This trial will explore the applicability of a new frontier of tele-medicine in infants.

This trial will explore the effectiveness of prism therapy (using base-out Fresnel prisms)and visual search therapy (using paper-based visual scanning training) versus standard care (advice only with no intervention).

This trial will explore more detailed information about the key markers of cachexia than previous work in this population group, particularly concerning the magnitude of inflammation experienced post PFF.

This investigator-initiated randomised placebo-controlled trial will explore the effect of exenatide once weekly on various metabolic parameters of importance in the schizophrenia population.

The trial will explore the archdiocese's relationship to the school and its responsibility for the training and supervision of teachers, issues that apparently have never been resolved in this context in New York.

Furthermore, the feasibility trial will explore the logistics and practicality of delivering brief advice to dental patients in a NHS dental setting.

Furthering our understanding of these processes will enable development and refinement of cell therapy for progressive MS. The phase II 'ACTiMuS' trial will explore the efficacy of intravenous infusion of autologous BM-derived cell therapy in progressive MS and its laboratory arm will explore the underlying mechanisms of any observed effect.

The trial will explore the extent to which previous trials may have failed to show efficacy as a result of the kind of people who participate in such trials, and the kinds of measures of adherence used, including the impact of measurement itself on adherence and HbA1c.

Future trials will explore strategies to engage a more diverse and representative sample.

Ideally, clinical trials will explore multiple promising agents, be studied in a context where historical outcome is known, and will be used for a specific clinical context for a single histology.

In addition to the plethora of current randomised, controlled trials, various nonrandomised clinical trials will explore the potential efficacy and safety of trastuzumab, bevacizumab, sorafenib, and erlotinib in combination with an AI as first-line or second-line therapy, and one trial will test the combination of anastrozole, fulvestrant and gefinitib in the neoadjuvant setting.